Potential novel targets in breast cancer

Current Pharmaceutical Biotechnology

Volumn 10, Issue 2, 2009, Pages 148-153

  Rameshwar, Pranela ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow; Breast cancer; Cancer stem cells; Gap junction; Mesenchymal stem cells

Indexed keywords

CONNEXIN 26; CONNEXIN 43; GAP JUNCTION PROTEIN; HYPOXIA INDUCIBLE FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA;

BREAST CANCER; CANCER STEM CELL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL RENEWAL; CYTOKINE PRODUCTION; GAP JUNCTION; HUMAN; LYMPH NODE METASTASIS; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STROMA CELL; BONE MARROW; BREAST TUMOR; CELL JUNCTION; CELL TRANSFORMATION; DRUG EFFECT; FEMALE; METABOLISM; METASTASIS; PATHOLOGY;

BONE MARROW; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GAP JUNCTIONS; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASM METASTASIS;

EID: 65549123742     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920109787315024     Document Type: Review

References (73)

1. Paget, S. (1889) The distribution of secondary growths in cancer of the breast. The Lancet, 133(3421), 571-573.
2. Kaplan, R.; Psaila, B. and Lyden, D. (2006) Bone marrow cells in the pre-metastatic niche within bone and beyond. Cancer Metastasis Rev., 25(4), 521-529.
3. Rao, G.; Patel, P.S.; Idler, S.P.; Maloof, P.; Gascon, P.; Potian, J.A. and Rameshwar, P. (2004) Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow, A model of early cancer progression. Cancer Res., 64(8), 2874-2881.
4. Moharita, A.L.; Taborga, M.; Corcoran, K.E.; Bryan, M.; Patel, P.S. and Rameshwar, P. (2006) SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood, 108(10), 3245-3252.
5. Oh, H.S.; Moharita, A.; Potian, J.G.; Whitehead, I.P.; Livingston, J.C.; Castro, T.A.; Patel, P.S. and Rameshwar, P. (2004) Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin I gene in breast cancer cells. Cancer Res., 64(17), 6327-6336.
6. Patel, H.J.; Ramkissoon, S.H.; Patel, P.S. and Rameshwar, P. (2005) Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc. Natl. Acad. Sci. USA, 102(48), 17436-17441.
7. Balic, M.; Lin, H.; Young, L.; Hawes, D.; Giuliano, A.; McNamara, G.; Datar, R.H. and Cote, R.J. (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res., 12(19), 5615-5621.
8. Alexandrova, E.; Sergieva, S.; Nikolova, V. and Danon, S. (2003) Bone marrow micrometastases as a prognostic factor in early breast cancer patients. J. BUON, 8(2), 133-137.
9. Langer, I.; Guller, U.; Koechli, O.; Berclaz, G.; Singer, G.; Schaer, G.; Fehr, M.; Hess, T.; Oertli, D.; Bronz, L.; Schnarwyler, B.; Wight, E.; Uehlinger, U.; Infanger, E.; Burger, D. and Zuber, M. (2007) Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients, Results of the Swiss Multicenter Study. Ann. Surg. Oncol., (In press)
10. Braun, S.; Kentenich, C.; Janni, W.; Hepp, F.; de Willgeroth, F.; Sommer, H. and Pantel, K. (2000) Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J. Clin. Oncol., 18(1), 80-86.
11. Braun, S., Pantel, K., Muller, P., Janni, W., Hepp, F., Kentenich, C.R.M. Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., Riethmuller, G. and Schlimok, G. (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with Stage I, II, or III breast cancer. N. Engl. J. Med., 342(8), 525-533.
12. Patel, S.A., Sherman, L., Munoz, J. and Rameshwar, P. (2008) Immunological properties of mesenchymal stem cells and clinical implications. Arch. Immunol. Ther. Exp., 56(1), 1-8.
13. Wulf, G.G.; Jorgens, B.; Liersch, T.; Gatzemeier, W.; Rauschecker, H.; Buske, C.; Hofner, M.; Hiddemann, W. and Wormann, B. (1997) Reverse transcriptase polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer. J. Cancer Res. Clin. Oncol., 123(9), 514-521.
14. Mansi, J.L.; Berger, U.; McDonnell, T.; Pople, A.; Rayter, Z.; Gazet, J.C. and Coombes, R.C. (1989) The fate of bone marrow micrometastases in patients with primary breast cancer. J. Clin. Oncol., 7(4), 445-449.
15. Murphy, P.M. (2001) Chemokines and the Molecular Basis of Cancer Metastasis. N. Engl. J. Med., 345(11), 833-835.
16. Donahue, H.J.; Saunders, M.M.; Li, Z.; Mastro, A.M.; Gay, C.V. and Welch, D.R. (2003) A potential role for gap junctions in breast cancer metastasis to bone. J. Musculoskelet. Neuronal. Interact., 3(2), 156-161.
17. Scadden, D.T. (2007) The stem cell niche in health and leukemic disease. Best Pract. Res. Clin. Haematol., 20(1), 19-27.
18. Wang, J.C.Y.; Dick, J.E. (2005) Cancer stem cells, lessons from leukemia. Trends Cell Biol., 15(9), 494-501.
19. Reya, T.; Morrison, S.J.; Clarke, M.F. and Weissman, I.L. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414(6859), 105-111.
20. Villadsen, R.; Fridriksdottir, A.J.; Ronnov-Jessen, L.; Gudjonsson, T.; Rank, F.; LaBarge, M.A.; Bissell, M.J. and Petersen, O.W. (2007) Evidence for a stem cell hierarchy in the adult human breast. J. Cell. Biol., 177(1), 87-101.
21. Bruce, W.R. and Gaagh, V.D. (1963) A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature, 199, 79-80.
22. Keith, B. and Simon, M.C. (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell, 129(3), 465-472.
23. Parmar, K.; Mauch, P.; Vergilio, J.A.; Sackstein, R. and Down, J.D. (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl Acad. Sci. USA, 104(13), 5431-5436.
24. Yin, T. and Li, L. (2006) The stem cell niches in bone. J. Clin. Invest. 116(5), 1195-1201.
25. Chow, D.C.; Wenning, L.A.; Miller, W.M. and Papoutsakis, E.T. (2001) Modeling pO2 distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian Models. Biophys. J., 81(2), 685-696.
26. Spillane, J.B. and Henderson, M.A. (2007) Cancer stem cells, A review. J. Surg., 77(6), 464-468.
27. Beier, D.; Hau, P.; Proescholdt, M.; Lohmeier, A.;Wischhusen, J.; Oefner, P.J.; Aigner, L.; Brawanski, A.; Bogdahn, U. and Beier, C.P. (2007) CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res., 67(9), 4010-4015.
28. Gu, G.; Yuan, J.; Wills, M. and Kasper, S. (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res., 67(10), 4807-4815.
29. Ho, M.M.; Ng, A.V.; Lam, S. and Hung, J.Y. (2007) Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res., 67(10), 4827-4833.
30. Bianco P, Riminucci M, Gronthos S and Robey PG. (2001) Bone marrow stromal stem cells, Nature, biology, and potential applications. Stem Cells, 19(3), 180-192.
31. Deans, R.A.; Moseley, A.B. (2000) Mesenchymal stem cells, Biology and potential clinical uses. Exp. Hematol., 28(8), 875-884.
32. Caplan, A.I. and Bruder, S.P. (2001) Mesenchymal stem cells, building blocks for molecular medicine in the 21st century. Trends Mol. Med., 7(6), 259-264.
33. Lamagna, C. and Bergers, G. (2006) The bone marrow constitutes a reservoir of pericyte progenitors. J. Leukoc. Biol., 80(4), 677-681.
34. Bergers G and Song S. (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro-oncology, 7(4), 452-464.
35. Schinkothe, T.; Bloch, W. and Schmidt, A. (2008) In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev., 17(1), 199-206.
36. Honczarenko, M.; Le, Y.; Swierkowski, M.; Ghiran, I.; Glodek, A.M. and Silberstein, L.E. (2006) Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells, 24(4), 1030-1041.
37. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z., Aslan, H. Galun, E. and Rachmilewitz, J. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105(5), 2214-2219.
38. Chan, J.L.; Tang, K.C.; Patel, A.P.; Bonilla, L.M.; Pierobon, N.; Ponzio, N.M. and Rameshwar, P. (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood, 107(12), 4817-4824.
39. Hinds, K.A.; Hill, J.M.; Shapiro, E.M.; Laukkanen, M.O.; Silva, A.C.; Combs, C.A.; Varney, T.R.; Balaban, R.S.; Koretsky, A.P. and Dunbar, C.E. (2003) Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood, 102(3), 867-872.
40. Kang, H.S.; Habib, M.; Chan, J.; Abavana, C.; Potian, J.A.; Ponzio, N.M. and Rameshwar, P. (2005) A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge. Exp. Hematol., 33(7), 796-803.
41. Potian, J.A.; Aviv, H.; Ponzio, N.M.; Harrison, J.S. and Rameshwar, P. (2003) Veto-Like activity of mesenchymal stem cells, Functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol., 171(7), 3426-3434.
42. Spaggiari, G.M.; Capobianco, A.; Becchetti, S.; Mingari, M.C. and Moretta, L. (2006) Mesenchymal stem cell-natural killer cell interactions, evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 107(4), 1484-1490.
43. Sasser, A.K.; Mundy, B.L.; Smith, K.M.; Studebaker, A.W.; Axel, A.E.; Haidet, A.M. Fernandez, S.A. and Hall, B.M. (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett., 254(2), 255-264.
44. Scherr, M. and Eder, M. (2007) Gene silencing by small regulatory RNAs in mammalian cells. Cell Cycle 6(4), 444-449.
45. Johnson, C. and Sundaresan, V. (2007) Regulatory small RNAs in plants. EXS, 97, 99-113.
46. Lewis, B.P.; Burge, C.B. and Bartel, D.P. (2005) Conserved sed piring, often flanked by adenosines, indicates that tousands of hman genes are microRNA trgets. Cell, 120(1), 15-20.
47. Calin, G.A. and Croce, C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6(11), 857-866.
48. Yang, Z. and Wu, J. (2007) MicroRNAs and regenerative medicine. DNA Cell. Biol., 26(4), 257-264.
49. Willecke, K.; Eiberger, J.; Degen, J.; Eckardt, D.; Romualdi, A.; Guldenagel, M.; Deutsch, U. and Sohl, G. (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol. Chem., 383(5), 725-737.
50. Laird, D.W. (2006) Life cycle of connexins in health and disease. Biochem. J., 394(Pt 3), 527-543.
51. Seez, J.C.; Berthoud, V.M.; Branes, M.C.; Martinez, A.D. and Beyer, E.C. (2003) Plasma membrane channels formed by connexins, Their regulation and functions. Physiol. Rev., 83(4), 1359-1400.
52. Hirschi, K.K.; Xu, C.E.; Tsukamoto, T. and Sager, R. (1996) Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ., 7(7), 861-870.
53. Monaghan, P.; Clarke, C.; Perusinghe, N.P.; Moss, D.W.; Chen, X.Y. and Evans, W.H. (1996) Gap junction distribution and connexin expression in human breast. Exp. Cell Res., 223(1), 29-38.
54. Monaghan, P. and Moss, D. (1996) Connexin Expression and GAP junctions in the mammary gland. Cell Biol. Intl., 20(2), 121-125.
55. Jamieson, S.; Going, J.J.; D'Arcy, R. and George, W.D. (1998) Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J. Pathol., 184(1), 37-43.
56. Wilgenbus, K.K.; Kirkpatrick, C.J.; Knuechel, R.; Willecke, K. and Traub, O. (1992) Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Intl. J. Cancer, 51(4), 522-529.
57. Shao, Q.; Wang, H.; McLachlan, E.; Veitch, G.I.L. and Laird, D.W. (2005) Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res., 65(7), 2705-2711.
58. Li, Z.; Zhou, Z. and Donahue, H.J. (2008) Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin. Exp. Metastasis, 25(3), 265-272.
59. McLachlan, E.; Shao, Q. and Laird, D. (2007) Connexins and gap junctions in mammary gland development and breast cancer progression. J. Memb. Biol., 218(1), 107-121.
60. Naoi, Y.; Miyoshi, Y.; Taguchi, T.; Kim, S.J.; Arai, T.; Maruyama, N.; Tamaki Y. And Noguchi S. (2008) Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett., 262(2), 248-256.
61. Laird, D.W.; Fistouris, P.; Batist, G.; Alpert, L.; Huynh, H.T.; Carystinos, G.D. and Alaoui-Jamali, M.A. (1999) Deficiency of Connexin43 gap junctions is an independent marker for breast tumors. Cancer Res., 59(16), 4104-4110.
62. Kanczuga-Koda, L.; Sulkowski, S.; Lenczewski, A.; Koda, M.; Wincewicz, A.; Baltaziak, M. and Sulkowska, M. (2006) Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J. Clin. Pathol., 59(4), 429-433.
63. Kalra, J.; Shao, Q.; Qin, H.; Thomas, T.; Aoui-Jamali, M.A. and Laird, D.W. (2006) Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis, 27(12), 2528-2537.
64. Conklin, C.M.J.; Bechberger, J.F.; MacFabe, D.; Guthrie, N.; Kurowska, E.M. and Naus, C.C. (2007) Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis, 28(1), 93-100.
65. McLachlan, E., Shao, Q., Wang, H.l., Langlois, S. and Laird, D.W. (2006) Connexins act as Tumor Suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res., 66(20), 9886-9894.
66. Boman, B.M.; Wicha, M.S.; Fields, J.Z. and Runquist, O.A. (2007) Symmetric division of cancer stem cells - a key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin. Pharmacol. Ther., 81(6), 893-898.
67. Psaila, B.; Kaplan, R.N.; Port, E.R. and Lyden, D. (2006) Priming the 'soil' for breast cancer metastasis, the pre-metastatic niche. Breast Dis., 26, 65-74.
68. Kaplan, R.; Psaila, B. and Lyden, D. (2006) Bone marrow cells in the 'pre-metastatic niche', within bone and beyond. Cancer Metastasis Rev., 25(4), 521-529.
69. Kaplan, R.N.; Psaila, B. and Lyden, D. (2007) Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med., 13(2), 72-81.
70. Steeg, P.S. (2005) Cancer biology, Emissaries set up new sites. Nature, 438(7069), 750-751.
71. Kaplan, R.N.; Riba, R.D.; Zacharoulis, S.; Bramley, A.H.; Vincent, L.; Costa, C.; MacDonald, D.D.; Jin, D.K.; Shido, K.; Kerns, S.A.; Zhu, Z.; Hicklin, D.; Wu, Y.; Port, J.L.; Altorki, N.; Port, E.R.; Ruggero, D.; Shmelkov, S.V.; Jensen, K.K.; Rafii, S. and Lyden, D. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820-827.
72. Ollivier, L.; Gerber, S.; Vanel, D.; Brisse, H. and Leclere, J. (2006) Improving the interpretation of bone marrow imaging in cancer patients. Cancer Imag., 6194-198.
73. Minn, A.J.; Kang, Y.; Serganova, I.; Gupta, G.P.; Giri, D.D.; Doubrovin, M. (2005) Ponomarev. V., Gerald, W.L., Blasberg, R. and Massagué. J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115(1), 44-55.